Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Immuneering Corporation Class A Common Stock | IMRX

AI Analysis of Immuneering Corporation Class A Common Stock

Immuneering saw some selling pressure today and moved down -3.11%

The company isn't at an immediate support or resistance level that might be predictive. Immuneering hasn't shown a lot of strength recently, shareholders don't seem that energized about the asset's future prospects. IMRX might find some support at the 5.66 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2026-07-23

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-